Rheum Round-up: Interview With Richard Furie, MD; Orthopedics’ Diversity Problem, and Much More
Interview: Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE
During the American College of Rheumatology (ACR) Convergence 2020, several presentations discussed data...
Healthcare Visits, DMARD Treatment Both Interrupted for Autoimmune Rheumatic Patients During COVID-19
The COVID-19 pandemic impacted virtually all areas of health care, whether it be access to medication, conversions to telemedicine, or a number of other...
Rheum Round-up: Sexual Harassment in Orthopedics, RA Drug Analysis, and more
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about the rate of sexual harassment...
Did COVID-19 Affect Outcomes for Inflammatory Rheumatic Disease Patients?
The COVID-19 pandemic does not appear to have significantly affected the disease course of patients with inflammatory rheumatic diseases including axial spondyloarthritis (axSpA), rheumatoid...
Secukinumab Does Not Increase Risk of TB Reactivation in Rheumatic Disease Patients
Human IgG1κ monoclonal antibody secukinumab used to treat patients with psoriatic arthritis (PsA), psoriasis (PsO), and ankylosing spondylitis was not associated with latent tuberculosis...
Rheum Round-up: Rituximab Biosimilar Comparison, Cognitive Behavioral Therapy for OA, and more
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about a rituximab biosimilar, switching from...
Sleep Disturbance, Fatigue, Anxiety/Depression Commonly Reported in PsA Patients
A recent study analyzed the prevalence of and factors associated with sleep disturbances, fatigue, and anxiety/depression among psoriatic arthritis (PsA) patients.
Decreased health-related quality of...
